Cabaletta Bio, Inc.CABANASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
5.81%
↓ 83% below average
Average (30q)
35.18%
Historical baseline
Range
High:710.33%
Low:-52.14%
Volatility
2167.6%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 5.81% |
| Q2 2025 | 29.71% |
| Q1 2025 | 13.65% |
| Q4 2024 | -2.88% |
| Q3 2024 | 12.22% |
| Q2 2024 | 6.71% |
| Q1 2024 | 26.14% |
| Q4 2023 | 26.24% |
| Q3 2023 | 16.87% |
| Q2 2023 | -5.13% |
| Q1 2023 | 0.28% |
| Q4 2022 | 50.93% |
| Q3 2022 | -13.64% |
| Q2 2022 | 3.75% |
| Q1 2022 | -7.55% |
| Q4 2021 | 21.42% |
| Q3 2021 | 4.06% |
| Q2 2021 | 19.74% |
| Q1 2021 | 13.52% |
| Q4 2020 | 2.21% |
| Q3 2020 | 5.98% |
| Q2 2020 | 15.39% |
| Q1 2020 | 52.68% |
| Q4 2019 | -6.02% |
| Q3 2019 | 20.87% |
| Q2 2019 | -3.51% |
| Q1 2019 | 122.84% |
| Q4 2018 | -52.14% |
| Q3 2018 | 710.33% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |